UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Astaxanthin attenuates glutamate-induced apoptosis via inhibition of calcium influx and endoplasmic reticulum stress

European journal of pharmacology, 2017-07, Vol.806, p.43-51

2017

Volltextzugriff (PDF)

Integrated microfluidic single-cell immunoblotting chip enables high-throughput isolation, enrichment and direct protein analysis of circulating tumor cells

Microsystems & nanoengineering, 2022-02, Vol.8 (1), p.13-13, Article 13

2022

Volltextzugriff (PDF)

Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer

Journal of medicinal chemistry, 2021-05, Vol.64 (9), p.5485-5499

2021

Volltextzugriff (PDF)

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin

Journal of medicinal chemistry, 2023-04, Vol.66 (8), p.5669-5684

2023

Volltextzugriff (PDF)

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin

Journal of medicinal chemistry, 2023-07, Vol.66 (13), p.8564-8579

2023

Volltextzugriff (PDF)

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer

Journal of medicinal chemistry, 2023-06, Vol.66 (11), p.7268-7279

2023

Volltextzugriff (PDF)

Developing a Ruthenium(III) Complex to Trigger Gasdermin E‑Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis

Journal of medicinal chemistry, 2023-09, Vol.66 (18), p.13072-13085

2023

Volltextzugriff (PDF)

Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy

Journal of medicinal chemistry, 2022-04, Vol.65 (7), p.5392-5406

2022

Volltextzugriff (PDF)

Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response

Journal of medicinal chemistry, 2024-03, Vol.67 (5), p.3843-3859

2024

Volltextzugriff (PDF)

Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis

Journal of medicinal chemistry, 2020-11, Vol.63 (22), p.13695-13708

2020

Volltextzugriff (PDF)

Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy

Journal of medicinal chemistry, 2021-05, Vol.64 (10), p.6777-6791

2021

Volltextzugriff (PDF)

Label-free Separation of Circulating Tumor Cells Using a Self-Amplified Inertial Focusing (SAIF) Microfluidic Chip

Analytical chemistry (Washington), 2020-12, Vol.92 (24), p.16170-16179

2020

Volltextzugriff (PDF)

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

Angewandte Chemie International Edition, 2024-09, p.e202411846

2024

Volltextzugriff (PDF)

Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer

Journal of medicinal chemistry, 2024-09

2024

Volltextzugriff (PDF)

Rational Design of a Hetero-multinuclear Gadolinium(III)–Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

Journal of medicinal chemistry, 2024-09, Vol.67 (17), p.15606-15619

2024

Volltextzugriff (PDF)

Developing a Copper(II) Isopropyl 2‑Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin–Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment

Journal of medicinal chemistry, 2024-04, Vol.67 (7), p.5744-5757

2024

Volltextzugriff (PDF)

Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis

Journal of inorganic biochemistry, 2024-01, Vol.250, p.112403-112403, Article 112403

2024

Volltextzugriff (PDF)

In vitro and In vivo anticancer activities of Bi(III) 2-thiazolecarboxaldehyde thiosemicarbazone complex

Journal of molecular structure, 2024-12, Vol.1318, p.139389, Article 139389

2024

Volltextzugriff (PDF)

Developing a Hetero-Trinuclear Erbium(III)-Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor

Journal of medicinal chemistry, 2023-11, Vol.66 (22), p.15424-15436

2023

Volltextzugriff (PDF)

Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response

Journal of medicinal chemistry, 2024-09

2024

Volltextzugriff (PDF)

Metal-Labeled Aptamers as Novel Nanoprobes for Imaging Mass Cytometry Analysis

Analytical chemistry (Washington), 2020-05, Vol.92 (9), p.6312-6320

2020

Volltextzugriff (PDF)

Novel Brain-Tumor-Inhibiting Copper(II) Compound Based on a Human Serum Albumin (HSA)-Cell Penetrating Peptide Conjugate

Journal of medicinal chemistry, 2019-12, Vol.62 (23), p.10630-10644

2019

Volltextzugriff (PDF)

Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment

Molecular pharmaceutics, 2020-04, Vol.17 (4), p.1405-1414

2020

Volltextzugriff (PDF)

Hydrogel in the treatment of traumatic brain injury

Biomaterials research, 2024-09

2024

Volltextzugriff (PDF)

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides

European journal of medicinal chemistry, 2019-11, Vol.182, p.111616-111616, Article 111616

2019

Volltextzugriff (PDF)

1 – 25 von 177

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(168)

Publikationsform

Sprache

Englisch
(177)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(75)
Technology
(53)
Physical Sciences
(40)
Computer Science
(32)
Pharmacology & Pharmacy
(31)
Chemistry
(28)
Humans
(27)
Chemistry, Medicinal
(25)
Engineering
(23)
Biochemistry & Molecular Biology
(18)
Animals
(15)
Cell Line, Tumor
(15)
Chemistry, Multidisciplinary
(13)
Proteins
(13)
Apoptosis
(12)
Computer Science, Information Systems
(12)
Materials Science
(12)
Genes
(11)
Physics
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Astaxanthin attenuates glutamate-induced apoptosis via inhibition of calcium influx and endoplasmic reticulum stress

Integrated microfluidic single-cell immunoblotting chip enables high-throughput isolation, enrichment and direct protein analysis of circulating tumor cells

Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer

Developing an Anticancer Platinum(II) Compound Based on the Uniqueness of Human Serum Albumin

Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin

Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer

Developing a Ruthenium(III) Complex to Trigger Gasdermin E‑Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis

Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy

Designing a Mitochondria-Targeted Theranostic Cyclometalated Iridium(III) Complex: Overcoming Cisplatin Resistance and Inhibiting Tumor Metastasis through Necroptosis and Immune Response

Developing a Novel Gold(III) Agent to Treat Glioma Based on the Unique Properties of Apoferritin Nanoparticles: Inducing Lethal Autophagy and Apoptosis

Developing a Novel Anticancer Gold(III) Agent to Integrate Chemotherapy and Immunotherapy

Label-free Separation of Circulating Tumor Cells Using a Self-Amplified Inertial Focusing (SAIF) Microfluidic Chip

Anticancer Tetranuclear Cu(I) Complex Catalyzes a Click Reaction to Synthesize a Chemotherapeutic Agent in situ to Achieve Targeted Dual‐Agent Combination Therapy for Cancer

Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer

Rational Design of a Hetero-multinuclear Gadolinium(III)–Copper(II) Complex: Integrating Magnetic Resonance Imaging, Photoacoustic Imaging, Mild Photothermal Therapy, Chemotherapy and Immunotherapy of Cancer

Developing a Copper(II) Isopropyl 2‑Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin–Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment

Novel mono-, bi-, tri- and tetra-nuclear copper complexes that inhibit tumor growth through apoptosis and anti-angiogenesis

In vitro and In vivo anticancer activities of Bi(III) 2-thiazolecarboxaldehyde thiosemicarbazone complex

Developing a Hetero-Trinuclear Erbium(III)-Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor

Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response

Metal-Labeled Aptamers as Novel Nanoprobes for Imaging Mass Cytometry Analysis

Novel Brain-Tumor-Inhibiting Copper(II) Compound Based on a Human Serum Albumin (HSA)-Cell Penetrating Peptide Conjugate

Human Serum Albumin-Based Dual-Agent Delivery Systems for Combination Therapy: Acting against Cancer Cells and Inhibiting Neovascularization in the Tumor Microenvironment

Hydrogel in the treatment of traumatic brain injury

Developing a binuclear multi-target Bi(III) complex by optimizing 2-acetyl-3-ethylpyrazine thiosemicarbazides

Suchergebnisse filtern